Problems raised by the simultaneous reproducibility of positive allergic patch test reactions in man - 12/10/17
Doi : 10.1016/S0190-9622(89)70265-6
Jean-Marie Lachapelle, MD, PhD ⁎, Jean-Luc Antoine, DSc, PhD
From the Unit of Occupational Dermatology, Catholic University of Louvain.
aReprint requests: Jean-Marie Lachapelle, MD, Unit of Occupational Dermatology, Catholic University of Louvain, UCL 3033, 30, Clos Chapelle-aux-Champs, B-1200 Brussels, Belgium.
Résumé |
The dose of petrolatum patch test material applied with the Leukotest or the Finn Chamber method varies significantly and is one important factor in the lack of reproducibility with present patch test methods. Ready-to-apply methods such as Epiquick and TRUE Test avoid this problem. In a right-side versus left-side comparative study of 19 Epiquick patches on 100 consecutive patients, the reproducibility was 95%. This is a much higher correlation than with previous comparative tests with both identical and different patch test systems.
Le texte complet de cet article est disponible en PDF.© 1989
Publié par Elsevier Masson SAS.
Vol 21 - N° 4P2
P. 850-854 - octobre 1989 Retour au numéro
Article précédent
- Comparative multicenter studies with TRUE Test and Finn Chambers in eight Swedish hospitals
- TRUE Test Study Group a *
- The development of the patch testing procedure and working for consistency
- Niels Hjorth
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?